Skip to main content
Log in

Continuous Hepatic Artery Infusion (CHAI) as Treatment of Liver Metastases

Are the Complications Worth It?

  • Leading Article
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Hohn DC, Stagg RJ, Friedman MA, Hannigan JF, Rayner A, et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group Trial. Journal of Clinical Oncology 7: 1646–1654, 1989

    PubMed  CAS  Google Scholar 

  • Hrushesky WJ. Circadian timing of cancer chemotherapy. Science 228: 73–79, 1985

    Article  PubMed  CAS  Google Scholar 

  • Hrushesky WJ, vonRoemeling R, Lanning RM. Circadian-shaped infusions of floxuridine for progressive metastatic renal cell carcinoma. Journal of Clinical Oncology 8: 1504–1513, 1990

    PubMed  CAS  Google Scholar 

  • Kemeny MM, Battifora H, Blaney DW, Cecchi G, Goldberg DA, et al. Sclerosing cholangitis after continuous hepatic artery infusion of FUDR. Annals of Surgery 202: 176–181, 1985

    Article  PubMed  CAS  Google Scholar 

  • Kemeny MM, Goldberg D, Beatty JD, Blayney D, Browning S, et al. Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. Cancer 57: 492–498, 1986

    Article  PubMed  CAS  Google Scholar 

  • Kemeny N, Daly J, Oderman P, Shike M, Chun H, et al. Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinoma. Journal of Clinical Oncology 6: 595–600, 1984

    Google Scholar 

  • Kemeny N, Daly J, Reichman B, Geller N, Botet J, et al. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. Annals of Internal Medicine 107: 459–465, 1987

    PubMed  CAS  Google Scholar 

  • Rougier P, Hay JM, Escat J, Laplanche A, Eilas D, et al. A controlled multicentric trial of intrahepatic chemotherapy (IHC) vs standard palliative treatment for colorectal liver metastases. American Society of Clinical Oncology, Poster 403, May 1990

  • Seiter K, Kemeny N, Berger M, Niedzwiecki, Chapman D, et al. A randomised trial of intrahepatic (IH) infusion of FUDR with dexamethasone (d) vs FUDR alone in the treatment of metastatic colorectal cancer. American Society of Clinical Oncology Proceedings 9: 418, 1990

    Google Scholar 

  • Stagg R, Venook A, Chase J, Grobman B, Lewis B, et al. Alternating hepatic IA FUDR & IA 5FU for colorectal liver metastases. International Conference on Advances in Regional Cancer Therapy, Berchtesgaden, West Germany, June 5–7, 1989. Abstract IV, 1989

  • von Roemeling R, Hrushesky WJ. Circadian patterning of continuous floxuridine infusion reduces toxicity and allows higher dose intensity in patients with widespread cancer. Journal of Clinical Oncology 7: 1710–1719, 1989

    Google Scholar 

  • Wagman LD, Kemeny MM, Leong L, Terz JJ, Hill LR, et al. A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. Journal of Clinical Oncology 8: 1885–1893, 1990

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kemeny, M.M. Continuous Hepatic Artery Infusion (CHAI) as Treatment of Liver Metastases. Drug-Safety 6, 159–165 (1991). https://doi.org/10.2165/00002018-199106030-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199106030-00001

Keywords

Navigation